WHO discontinue trial of hydroxychloroquine in COVID-19 cases owing to safety issues
Hydroxychloroquine has been promoted by Donald Trump and several others as a potential treatment for the illness resulted from the new coronavirus. The U.S. President has stated he has started consuming the medication to help avoid the infection.
On Monday, WHO Director-General Tedros Adhanom Ghebreyesus stated that the World Health Organization has discontinued testing the malaria medication hydroxychloroquine in the COVID-19 patients because of safety issues.
Hydroxychloroquine has been promoted by Donald Trump and several others as a potential treatment for the illness which is caused by the brand new coronavirus. The U.S. President has stated that he was consuming the drug to help avoid the infection.
“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,” Tedros mentioned in an online statement.
He stated the other branch of the testing – a large international initiative to conduct clinical trials of possible treatments for the virus – was continuing.
The WHO had earlier suggested against using hydroxychloroquine to cure or contain the spread of the virus, excluding as part of clinical testing.
Dr Mike Ryan, chief of the WHO emergency programme, told that the decision to discontinue tests of hydroxychloroquine had been taken as “an abundance of caution”.